In this article, we will take a look at the 20 Best Low Volatility Stocks to Buy According to Analysts.
Consumers remain cautious about potential price hikes, but their biggest concerns about tariff-induced inflation have subsided, according to a University of Michigan survey published on July 18. Overall mood rose 1.8% from June to 61.8, the highest level since February and precisely in line with the Dow Jones consensus projection, according to the university’s widely followed July Survey of Consumers.
Both the one- and five-year outlooks for inflation plummeted, hitting their lowest points since February, before President Donald Trump announced his “liberation day” tariffs on April 2. Concerns about inflation reached their peak when the President imposed 10% blanket tariffs alongside reciprocal tariffs, though he retracted this stance on pending negotiations. He has, however, recently declared tariffs on certain products, including copper, which raises the possibility of further price hikes.
Speaking on this, Jeffrey Roach, chief economist at LPL Financial, said the following:
“Despite risks of rising consumer inflation in the next few months, consumers have well-anchored expectations that tariff inflation will be temporary, and that conditions should improve by the time we enter 2026. Inflation expectation is an important factor for the Fed and according to this report, the trajectory looks encouraging.”
This past week also marked the start of earnings season, which provided American companies with a chance to prove whether tariffs were affecting their operations or not. Of the 59 S&P 500 companies to first report their second-quarter earnings, 81.4% have exceeded Wall Street’s earnings projections.
Our Methodology
For this list, we used screeners to note down some of the best low volatility stocks to buy. The following firms have low beta values (<1) and possess robust business fundamentals. These stocks are ranked in ascending order based on their average share price upside potential. Additionally, we have mentioned the hedge fund sentiment around each stock, as of Q1 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
20. PepsiCo, Inc. (NASDAQ:PEP)
Analyst Upside: 6.71%
Beta Value: 0.46
Number of Hedge Fund Holders: 71
PepsiCo, Inc. (NASDAQ:PEP) ranks among the best low volatility stocks to buy according to analysts. On July 15, PepsiCo, Inc. (NASDAQ:PEP) and Cargill announced that they would collaborate to apply regenerative agriculture practices to 240,000 acres of farmland in Iowa by 2030. The initiative will focus on the companies’ joint corn supply chain in Iowa, where Cargill acquires ingredients for PepsiCo products from nearby farmers.
The partnership advances the environmental objectives of both companies, such as PepsiCo’s expanded goal to apply regenerative methods on 10 million acres worldwide by 2030 and Cargill’s comparable 10 million-acre goal in North America.
Access to technical resources, incentive payments to lower the risk of implementing new techniques, and agronomic advice will all be provided to participating farmers. In addition to managing enrollment, Practical Farmers of Iowa will supervise result assessment and verification for the initiative.
One of the most well-known names in the world, PepsiCo, Inc. (NASDAQ:PEP) is an American multinational company involved in the food, snack, and beverage sectors.
19. NextEra Energy, Inc. (NYSE:NEE)
Analyst Upside: 6.99%
Beta Value: 0.62
Number of Hedge Fund Holders: 75
NextEra Energy, Inc. (NYSE:NEE) ranks among the best low volatility stocks to buy according to analysts. UBS reaffirmed its Buy rating on NextEra Energy, Inc. (NYSE:NEE) on July 2 with a price target of $84, pointing to encouraging developments in the recently concluded budget reconciliation bill. Important clauses like safe harbor and tax transferability were preserved in the budget bill, according to UBS, which gives NextEra an extension for safe harbor operations and an operational runway through 2029.
UBS noted that excise taxes were eliminated in the final draft of the bill, which was another win for the company. According to the firm, NextEra Energy, Inc. (NYSE:NEE) shares recovered 8% from their low point during intraday trading on July 1. The firm also stated that, based on its 2027 earnings projection of $4.33, the stock currently trades at a 3% premium to the broader Utility group.
One of the top utility companies in North America, NextEra Energy, Inc. (NYSE:NEE), produces, transmits, and distributes electricity. The company also runs electric generating facilities in wholesale energy markets and engages in energy commodity trading.
18. Johnson & Johnson (NYSE:JNJ)
Analyst Upside: 7.50%
Beta Value: 0.40
Number of Hedge Fund Holders: 91
Johnson & Johnson (NYSE:JNJ) ranks among the best low volatility stocks to buy according to analysts. On July 16, Stifel maintained its Hold rating on Johnson & Johnson (NYSE:JNJ), but increased its price target for the healthcare giant from $155 to $165. The price target increase comes after JNJ revised its outlook, which now predicts adjusted operational revenue growth of roughly 3.5% instead of the 2.5% midpoint estimate that was previously projected.
Johnson & Johnson (NYSE:JNJ) also raised its outlook for full-year earnings per share from $10.50 to $10.70 to a range of $10.80 to $10.90. The company cited stronger top-line performance, currency effects, and a lower anticipated impact from tariffs for this improvement. From its initial estimate of $400 million, the healthcare company now projects a $200 million tariff impact in 2025.
Johnson & Johnson (NYSE:JNJ) is a notable name in the healthcare industry, which includes sub-sectors like pharmaceuticals, medical equipment, and consumer health products. The company is known for creating medications to treat a variety of conditions and diseases, including cancer, diabetes, and HIV/AIDS.
17. Chevron Corporation (NYSE:CVX)
Analyst Upside: 7.62%
Beta Value: 0.84
Number of Hedge Fund Holders: 81
Chevron Corporation (NYSE:CVX) ranks among the best low volatility stocks to buy according to analysts. UBS reaffirmed its Buy rating and price target of $177 on Chevron Corporation (NYSE:CVX) on July 11 in anticipation of the oil giant’s 2025 second-quarter earnings report. Given the decline in oil prices, the investment bank expects Chevron to post reduced quarter-over-quarter profitability. However, it also expects its Permian Basin, Gulf of America, and Tengizchevroil (TCO) assets to perform well.
The planned acquisition of Hess Corporation is still the main focus of Chevron Corporation (NYSE:CVX) investors, according to UBS, which predicts the transaction will conclude in the third quarter of 2025.
The next major event after the Hess merger is Chevron’s November Analyst Day, where, according to the investment bank, the company is likely to present its growth strategy.
Chevron Corporation (NYSE:CVX), based in San Ramon, California, is a major American global energy company that specializes in the oil and gas industry. Founded as the Standard Oil Company of California, it is the second-largest direct descendant of Standard Oil.
16. Amgen Inc. (NASDAQ:AMGN)
Analyst Upside: 8.96%
Beta Value: 0.48
Number of Hedge Fund Holders: 96
Amgen Inc. (NASDAQ:AMGN) ranks among the best low volatility stocks to buy according to analysts. While keeping its Outperform rating, BMO Capital lowered its price target for Amgen Inc. (NASDAQ:AMGN) from $346 to $335 on July 9. Amgen’s narrative now “flips commercial” with a further MariTide catalyst not expected until later this year, according to the firm, which attributed the change in large part to a “mixed MariTide readout” at the American Diabetes Association (ADA) conference.
Following what it called “disappointing data” provided at the ADA meeting, the company lowered its peak sales expectations for Amgen’s MariTide from $3.64 billion to $2.14 billion in adjusted global peak sales spanning both Obesity and Type 2 Diabetes.
However, BMO Capital said that numerous Amgen Inc. (NASDAQ:AMGN) medications, such as Evenity, Repatha, and Tezspire, showed solid year-over-year prescription trends, with their updated forecasts now set at $495 million, $684 million, and $374 million.
Amgen Inc. (NASDAQ:AMGN) is a global biopharmaceutical company that focuses on human treatments for cardiovascular, hematology, inflammation, cancer, and bone health.
15. Philip Morris International Inc. (NYSE:PM)
Analyst Upside: 9.50%
Beta Value: 0.52
Number of Hedge Fund Holders: 104
Philip Morris International Inc. (NYSE:PM) ranks among the best low volatility stocks to buy according to analysts. While maintaining its Neutral rating on Philip Morris International Inc. (NYSE:PM), UBS increased its price target for the tobacco giant’s stock from $170 to $181 on July 14. The price target increase is in line with UBS’s revised earnings per share estimates, which were increased by 0.4% for fiscal year 2025, 5.1% for fiscal year 2026, and 5.0% for fiscal year 2027.
UBS emphasized Philip Morris’s impressive growth in Smoke-Free gross margins, which are expected to rise from 60.7% in fiscal year 2022 to 70.9% in fiscal year 2025. This improvement is bolstered by scale/productivity gains from IQOS and U.S. ZYN products, which have margins of about 85%.
With fiscal year 2025 projections of 873 million cans and $2.9 billion in revenues, the firm observed robust volume growth for ZYN in the US market, aided by inventory replenishment.
Philip Morris International Inc. (NYSE:PM) is a global tobacco company that provides services to consumers in over 180 countries. With Marlboro as its signature product, the firm stands out among the titans of “Big Tobacco.”
14. Lockheed Martin Corporation (NYSE:LMT)
Analyst Upside: 10.92%
Beta Value: 0.27
Number of Hedge Fund Holders: 68
Lockheed Martin Corporation (NYSE:LMT) ranks among the best low volatility stocks to buy according to analysts. The US Department of Defense awarded Lockheed Martin Corporation (NYSE:LMT) a $58.47 million firm-fixed-price contract for the maintenance of relay control elements on July 14. The contract covers the maintenance, modernization, and modification of relay control element systems.
Lockheed was the only company that was given consideration for the contract, as it was obtained through a sole-source acquisition method. At the time of the award, the DoD had already committed $5.8 million from fiscal 2025 operations and maintenance appropriations funds.
Moreover, Lockheed Martin Corporation (NYSE:LMT) had already won a separate $27.4 million contract from the DoD to supply F/A-18 aircraft components three days earlier. All work will be done at the company’s Orlando location, and the contract is part of an already awarded arrangement.
Lockheed Martin Corporation (NYSE:LMT), created by the 1995 merger of Lockheed Corporation and Martin Marietta, is a global leader in aerospace, defense, weaponry, information security, and technology.
13. AbbVie Inc. (NYSE:ABBV)
Analyst Upside: 10.92%
Beta Value: 0.50
Number of Hedge Fund Holders: 86
AbbVie Inc. (NYSE:ABBV) ranks among the best low volatility stocks to buy according to analysts. Ahead of the company’s second-quarter earnings report, JPMorgan reaffirmed its Overweight rating and $200 price target on AbbVie Inc. (NYSE:ABBV) on July 10.
Citing ongoing strength from Skyrizi and Rinvoq products as well as slight foreign exchange tailwinds that could result in another guidance raise, the firm expects AbbVie Inc. (NYSE:ABBV) to be well-positioned heading into the results. JPMorgan’s quarterly projections, which predict $15 billion in sales and $2.87 in earnings per share, are in line with market consensus.
According to JPMorgan, AbbVie Inc. (NYSE:ABBV) is in a solid spot as it won’t lose any significant exclusivity events until the mid-2030s, Moveover, the firm states that Skyrizi and Rinvoq can grow further, while the financial sheet has room for more business development to meet growth demands in the 2030s.
AbbVie Inc. (NYSE:ABBV) is a biopharmaceutical company that specializes in developing, manufacturing, and marketing therapies for complicated and chronic illnesses. Its next-generation immunology medications, Rinvoq and Skyrizi, continue to drive growth.
12. Linde plc (NASDAQ:LIN)
Analyst Upside: 11.10%
Beta Value: 0.93
Number of Hedge Fund Holders: 75
Linde plc (NASDAQ:LIN) ranks among the best low volatility stocks to buy according to analysts. Linde plc (NASDAQ:LIN) announced on June 23 that it had agreed to a long-term contract to supply industrial gases to Blue Point Number One’s low-carbon ammonia facility in Ascension Parish, Louisiana.
With an anticipated start date of 2029, the industrial gas company will allocate over $400 million to construct, own, and run an air separation unit (ASU) that will provide oxygen and nitrogen to the Blue Point project.
Linde’s current syngas and hydrogen infrastructure in the area will be complemented by the new ASU, which will be the largest in the Mississippi River corridor in southeast Louisiana. This is Linde’s third ASU to supply a large autothermal reforming plant, with the other two in Canada and Texas.
Linde plc (NASDAQ:LIN) is a global engineering and industrial gases company that generates and delivers process gases, including carbon dioxide and hydrogen, as well as related equipment and technologies.
11. McDonald’s Corporation (NYSE:MCD)
Analyst Upside: 11.63%
Beta Value: 0.52
Number of Hedge Fund Holders: 75
McDonald’s Corporation (NYSE:MCD) ranks among the best low volatility stocks to buy according to analysts. KeyBanc reaffirmed its Overweight rating and $325 price target for McDonald’s Corporation (NYSE:MCD) on July 15. Despite falling short of original projections, the firm expects McDonald’s to report “respectable” same-store sales growth of about 2% in the US for the second quarter of 2025.
KeyBanc believes McDonald’s Corporation (NYSE:MCD) likely performed better in the second quarter than its rivals, including Wendy’s, which had a rough time in the same period. The firm added that McDonald’s has a “solid pipeline of innovation/brand activations” scheduled for the second half of the year and that the recent Snack Wrap launch seems to have done well in its early days.
McDonald’s Corporation (NYSE:MCD) is the world’s largest chain of fast food restaurants. Founded in 1955 as a single drive-in restaurant in San Bernardino, California, it has expanded into a global behemoth with about 40,000 locations in more than 100 countries, serving approximately 60 million customers annually.
10. Exxon Mobil Corporation (NYSE:XOM)
Analyst Upside: 11.75%
Beta Value: 0.50
Number of Hedge Fund Holders: 94
Exxon Mobil Corporation (NYSE:XOM) ranks among the best low volatility stocks to buy according to analysts. Wells Fargo analyst Roger Read kept his Buy rating on Exxon Mobil Corporation (NYSE:XOM) on July 9 while keeping to his $127 price target. Even though the Q2 2025 EPS estimate was revised downward to $1.55, the changes show a balanced view, with reduced projections in Upstream and Chemicals somewhat offset by higher expectations in Energy Products.
Exxon Mobil’s earnings considerations remains slightly higher than the midpoint of the company’s guidance, according to Read’s report, indicating a consistent performance. Furthermore, the range of possible outcomes for the second quarter of 2025, based on actual results and the updated forecast, support a bullish view.
Read also stated expectation’s that management would discuss macroeconomic issues and strategic ambitions during the earnings call. These discussions could offer valuable information about future growth and capital allocation plans.
Exxon Mobil Corporation (NYSE:XOM) engages in the production, trade, transportation, and sale of crude oil, natural gas, petroleum products, petrochemicals, and specialized goods.
9. ServiceNow, Inc. (NYSE:NOW)
Analyst Upside: 13.37%
Beta Value: 0.94
Number of Hedge Fund Holders: 106
ServiceNow, Inc. (NYSE:NOW) ranks among the best low volatility stocks to buy according to analysts. ServiceNow, Inc. (NYSE:NOW) announced forming a partnership with Ferrari on July 9 to improve the performance of the automaker’s Hypercar team and race operations through its One Digital Portal.
The Ferrari Hypercar team makes use of a custom application built on ServiceNow’s platform that tracks and reports car defects, communicates updates on new components under testing, and ensures traceability throughout the validation process.
Additionally, the One Digital Portal supports Ferrari’s global dealer network by acting as a central hub for managing service requests throughout the Racing, Sports Car, and Lifestyle divisions.
ServiceNow, Inc. (NYSE:NOW) is a leading provider of cloud-based software solutions that enable corporations to streamline their digital workflows. The company operates the Now platform, a cloud-based platform with integrated AI that aids governments and multinational companies in digitizing their processes.
8. AT&T Inc. (NYSE:T)
Analyst Upside: 13.72%
Beta Value: 0.42
Number of Hedge Fund Holders: 87
AT&T Inc. (NYSE:T) ranks among the best low volatility stocks to buy according to analysts. On July 7, BofA Securities resumed coverage of AT&T Inc. (NYSE:T) with a Buy rating and a price target of $32. The firm attributes the optimistic forecast in large part to AT&T’s balanced approach to increasing growth through its owned fiber and wireless assets.
The positive outlook is further supported by AT&T’s robust return on capital plans, targeted at $40 billion. Additionally, the company stands to gain a great deal from the possible return of bonus depreciation, which BofA projects could boost free cash flow by 21% in 2026 and 26% in 2027.
According to BofA’s 2026 expected EV/EBITDA metrics, AT&T Inc. (NYSE:T) is now trading at a 30% discount to T-Mobile and a 9% premium to Verizon. The firm believes that with AT&T’s operational momentum, this gap in valuation should narrow.
AT&T Inc. (NYSE:T), the world’s largest telecommunications business and the leading supplier of mobile phone services in the United States, is a multinational conglomerate holding corporation headquartered in Texas that offers telecommunications, media, and technology services.
7. T-Mobile US Inc. (NASDAQ:TMUS)
Analyst Upside: 15.36%
Beta Value: 0.61
Number of Hedge Fund Holders: 75
T-Mobile US, Inc. (NASDAQ:TMUS) ranks among the best low volatility stocks to buy according to analysts. Redburn-Atlantic upgraded its rating of T-Mobile US, Inc. (NASDAQ:TMUS) from Sell to Neutral on July 7 with a price target of $228. The upgrade came despite Redburn-Atlantic’s worries that T-Mobile may be vulnerable to a prolonged slowdown in market net additions.
According to the firm, T-Mobile US, Inc. (NASDAQ:TMUS) may be the most susceptible to any coordinated market shift toward convergence since it has the least developed fiber strategy of the three major wireless companies.
Despite these reservations, the firm recognized T-Mobile’s track record of fulfilling mid-term financial projections and noted that, on the majority of multiples, T-Mobile US, Inc. (NASDAQ:TMUS) will be on par with or cheaper than AT&T by 2027 while expanding faster.
Based in Bellevue, Washington, T-Mobile US, Inc. (NASDAQ:TMUS) is a well-known supplier of wireless telecommunication services. Renowned for its strides in the 5G space, the company has built one of the largest and fastest 5G networks in the US, setting itself up for long-term success.
6. Costco Wholesale Corporation (NASDAQ:COST)
Analyst Upside: 15.36%
Beta Value: 0.97
Number of Hedge Fund Holders: 93
Costco Wholesale Corporation (NASDAQ:COST) ranks among the best low volatility stocks to buy according to analysts. William Blair reaffirmed its Outperform rating on Costco Wholesale Corporation (NASDAQ:COST) on July 10 as the company announced monthly sales of $26.4 billion for June 2025, an 8.0% year-over-year increase.
The addition of 25 new warehouses, which represented a 2.8% unit expansion, and comparative sales growth of 5.8% were the main drivers behind the sales growth. After two months of sequentially weaker performance, June comparative sales showed a reacceleration, primarily as a result of foreign exchange tailwinds that had been putting pressure on results for 14 months.
US adjusted comparable sales increased 5.5%, representing a two-year stack of 11.8% that was in line with the trailing twelve-month average of 11.7%. Adjusted comparable sales increased 7.9% for Canadian operations and 8.2% for other international markets.
A membership-based warehouse club, Costco Wholesale Corporation (NASDAQ:COST) offers bulk discounts on an array of products, including food, electronics, and household products.
5. Verizon Communications Inc. (NYSE:VZ)
Analyst Upside: 16.57%
Beta Value: 0.36
Number of Hedge Fund Holders: 65
Verizon Communications Inc. (NYSE:VZ) ranks among the best low volatility stocks to buy according to analysts. With a $47 price target and an Equalweight rating, Morgan Stanley resumed covering Verizon Communications Inc. (NYSE:VZ) on July 10. As the company is trading at a minor discount to its peer group, the firm believes that VZ shares have a balanced risk-reward profile at current prices. This is in line with Morgan Stanley’s projected adjusted EBITDA growth rate of 2-3%.
The firm presented a bull case price target of $54, which would represent the advantages of faster expansion in the broadband and consumer wireless segments. In this scenario, adjusted EBITDA growth could reach 3-3.5% annually, potentially enabling Verizon Communications Inc. (NYSE:VZ) shares to close the valuation gap with AT&T.
Verizon Communications Inc. (NYSE:VZ) is a leading provider of technology, entertainment, and communication services worldwide. The company offers a range of services through its operational divisions, such as digital TV, high-speed internet, and 5G and 4G wireless connectivity.
4. Abbott Laboratories (NYSE:ABT)
Analyst Upside: 21.27%
Beta Value: 0.71
Number of Hedge Fund Holders: 70
Abbott Laboratories (NYSE:ABT) ranks among the best low volatility stocks to buy according to analysts. RBC Capital maintained its Outperform rating on Abbott Laboratories (NYSE:ABT) on July 15 and raised its price target from $145 to $147. The firm pointed to Abbott’s strong single-digit revenue and double-digit EPS growth potential as examples of its ability to provide top-tier financial growth in the medical technology industry.
According to RBC Capital’s intra-quarter checks, Abbott Laboratories (NYSE:ABT) maintains positive healthcare utilization in Q2. Moreover, Abbott’s diabetes brand, which has been attracting a lot of investor interest, was one of the several growth catalysts mentioned in the firm’s report. The less elective nature of Abbott’s medical device portfolio was also mentioned by RBC as a benefit.
RBC Capital’s sustained belief in Abbott Laboratories (NYSE:ABT) as the best-performing large cap in its coverage year-to-date is bolstered by other positives such as business momentum in diabetes care, favorable trends in diagnostics, stability in nutrition, and strength in established pharmaceuticals.
Abbott Laboratories (NYSE:ABT) is a leading global healthcare company that manufactures a wide range of branded generic medications, medical devices, diagnostics, and nutritional items.
3. UnitedHealth Group Incorporated (NYSE:UNH)
Analyst Upside: 23.22%
Beta Value: 0.45
Number of Hedge Fund Holders: 139
UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best low volatility stocks to buy according to analysts. On July 15, Leerink Partners maintained its Outperform rating on UnitedHealth Group Incorporated (NYSE:UNH) but lowered its price target from $355 to $340. The firm noted that as the market awaits UnitedHealth to reinstate its 2025 financial forecast, investor expectations have been “moderately fading” over the past month.
According to Leerink Partners, the market typically anticipates earnings between $18 and $19 per share, so guidance in this range should allay worries due to the “materiality of the reduction in overall margins.”
Such a forecast, according to the analyst report, would lay the foundation for a “multi-year margin story,” with growth possibly picking up speed in 2027 as UnitedHealth Group Incorporated (NYSE:UNH) departs V28.
UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.
2. Thermo Fisher Scientific Inc. (NYSE:TMO)
Analyst Upside: 28.88%
Beta Value: 0.74
Number of Hedge Fund Holders: 101
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) but reduced its price target from $570 to $550. Citing current low levels and market mood, the firm believes an in-line second quarter will be enough to lift TMO shares, with earnings scheduled for July 23.
According to TD Cowen, biopharma activity was typical in the second quarter and was untouched by tariff or MFN issues, which the firm considers to be encouraging news. With expectations for “similar” organic growth to the first quarter, the firm reduced its second-quarter organic growth estimate from 1.2% to 1.0%, which was lower than the analysts’ consensus of 0.7%.
One of the top biotech and life sciences companies in the United States, Thermo Fisher Scientific Inc. (NYSE:TMO) offers a broad range of products and services. The company has grown significantly since its founding, mostly as a result of a number of well-timed acquisitions, such as those of Affymetrix and Life Technologies.
1. Eli Lilly and Company (NYSE:LLY)
Analyst Upside: 30.84%
Beta Value: 0.44
Number of Hedge Fund Holders: 119
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, Guggenheim reiterated its Buy rating on Eli Lilly & Company (NYSE:LLY) ahead of the company’s second-quarter earnings report and increased its price target from $936 to $942.
In contrast to the consensus predictions of $4.39 billion from VisibleAlpha and $4.89 billion from FactSet, the firm projects second-quarter Mounjaro sales of $4.49 billion. Guggenheim also predicts that Zepbound will rake in $3.10 billion in US sales in the second quarter, which is marginally more than the $2.94 billion consensus estimate.
Guggenheim’s modified model also takes into account a projected $0.14 effect on earnings per share from second-quarter IPR&D, as well as improved tirzepatide expectations based on prescription analysis.
The firm also emphasized that investors are paying close attention to net price and prescription trends for tirzepatide, as well as a number of important clinical trial readouts scheduled through the end of 2025.
Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world’s largest pharmaceutical companies.
While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
